Psmb9tm1Stl
Targeted Allele Detail
|
Symbol: |
Psmb9tm1Stl |
Name: |
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2); targeted mutation 1, Susumu Tonegawa |
MGI ID: |
MGI:2152729 |
Synonyms: |
LMP2 - |
Gene: |
Psmb9 Location: Chr17:34401006-34406347 bp, - strand Genetic Position: Chr17, 17.98 cM
|
Alliance: |
Psmb9tm1Stl page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:21549
|
Parent Cell Line: |
E14 (ES Cell)
|
Strain of Origin: |
129P2/OlaHsd
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutations: |
|
Insertion, Intragenic deletion
|
|
|
Mutation details: A 0.8-kb region, containing a 3' portion of exon 2, was replaced by a neomycin selection cassette. Western analysis of extracts from homozygous mutant mice showed that the encoded protein was absent and that Psmb8 protein levels were unaffected.
(J:21549)
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | involves: 129P2/OlaHsd * C57BL/6 | | | | involves: 129P2/OlaHsd * C57BL/6 | |
|
Phenotypes: |
Affected Systems |
|
|
|
hematopoietic system
|
√
|
|
decreased CD8-positive, alpha-beta T cell number
|
√
|
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
√
|
|
immune system
|
√
|
|
decreased CD8-positive, alpha-beta T cell number
|
√
|
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
√
|
|
abnormal immune system physiology
|
√
|
|
increased susceptibility to Orthomyxoviridae infection
|
√
|
|
liver/biliary system
|
√
|
|
increased hepatocellular carcinoma incidence
|
√
|
|
muscle
|
√
|
|
increased leiomyosarcoma incidence
|
√
|
|
neoplasm
|
√
|
√
|
increased tumor incidence
|
|
√
|
increased hepatocellular carcinoma incidence
|
√
|
|
increased lymphoma incidence
|
|
√
|
increased sarcoma incidence
|
|
√
|
increased leiomyosarcoma incidence
|
√
|
|
increased lung tumor incidence
|
√
|
|
respiratory system
|
√
|
|
increased lung tumor incidence
|
√
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:21549 Van Kaer L, et al., Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1994 Oct;1(7):533-41 |
All: |
38 reference(s) |
|